161 |
Exploitation of host cellular pathways by Chlamydia trachomatisBanhart, Sebastian 11 January 2012 (has links)
Wie auch andere bakterielle Pathogene überträgt C. trachomatis Effektorproteine in die Wirtszelle, um deren Funktionen zu manipulieren. Das während der Invasion sekretierte Effektorprotein Tarp besitzt N-terminale SH2-Bindungsstellen und eine C-terminale SH3-Bindungsstelle für die Interaktion mit Wirtszellproteinen. Zur Bestimmung dieser Interaktionen wurden Protein-Microarrays mit nahezu alle humanen SH2- und SH3-Domänen verwendet. Zahlreiche neue Interaktionen wurden detektiert, wobei das Adaptorprotein SHC1 eine der stärksten SH2-abhängigen Interaktionen mit Tarp zeigte. Mittels Transkriptionsanalyse SHC1-abhängiger Genregulation während der Infektion konnten Gene identifiziert werden, welche an der Apoptose- und Zellwachstumskontrolle beteiligt sind. Infizierte Wirtszellen mit SHC1-Knockdown wiesen eine erhöhte Apoptoserate nach Stimulation mit TNF-alpha auf. Diese Ergebnisse offenbaren eine wichtige Rolle von SHC1 im Kontext des frühen, Chlamydien-induzierten Wirtszellüberlebens und deuten darauf hin, dass Tarp als vielseitige Signaltransduktionsplattform dient. Um Wirtszelllipide aufzunehmen, nutzt C. trachomatis Transportrouten der Wirtszelle und modifiziert Lipide bei der Aufnahme. Zur Bestimmung der Lipidzusammensetzung der Wirtszelle wurde diese mittels MALDI-TOF-Massenspektrometrie analysiert. Dabei hatte die Infektion den stärksten Einfluss auf Phosphatidylinoslitol (PI)- und Cardiolipin (CL)-Spezies. Des Weiteren konnten im Infektionsverlauf PI- und CL-Spezies mit einem Massenunterschied von 14 Da detektiert werden, was auf verzweigtkettige Fettsäurereste chlamydialen Ursprungs und eine Beteiligung der cytosolischen Phospholipase A2 (cPLA2) hindeutet. Entsprechend zeigten infizierte Zellen mit einem Knockdown von cPLA2 oder der Cardiolipinsynthase 1 eine signifikant reduzierte Bildung infektiöser Bakterien. Dies unterstreicht die Bedeutung von CL und einer funktionellen Nährstoffversorgung für die erfolgreiche Vermehrung von C. trachomatis. / Like many bacterial pathogens, C. trachomatis translocates effector proteins into the host cell to manipulate host cell functions. The early phase effector protein Tarp harbors N-terminal SH2 binding sites and a C-terminal SH3 binding site for the interaction with host cell proteins. To assess these interactions, protein microarrays comprising virtually all human SH2 and SH3 domains were used. Numerous novel interactions were discovered, while the adaptor protein SHC1 was among Tarp’s strongest SH2-dependent interaction partners. Transcriptome analysis of SHC1-dependent gene regulation during infection indicated that SHC1 regulates apoptosis- and growth-related genes. SHC1 knockdown sensitized infected host cells to TNF-alpha-induced apoptosis. These findings reveal a critical role for SHC1 in early Chlamydia-induced cell survival and suggest that Tarp functions as an important multivalent signaling hub. To acquire host-derived lipids, C. trachomatis hijacks cellular trafficking pathways and modifies lipids during the acquisition. To assess infection-dependent changes of the host cell lipid composition, cells were analyzed by MALDI-TOF mass spectrometry. Phosphatidylinositol (PI) and cardiolipin (CL) levels were most prominently influenced by C. trachomatis infection. Furthermore, PI and CL species with a 14 Da mass difference were detected during the course of infection, indicating the presence of Chlamydia-derived branched chain fatty acids and a role of cytosolic phospholipase A2 (cPLA2) in this process. Accordingly, infection of cPLA2 or cardiolipin synthase 1 knockdown cells resulted in a significantly reduced formation of infectious particles. These data demonstrate the importance of cardiolipin and a functional nutrient supply for the successful propagation of C. trachomatis.
|
162 |
Establishment of a two-dimensional electrophoresis map of human mitochondrial proteinsXie, Jing 15 December 2003 (has links)
Mitochondriopathien sind Multisystemerkrankungen die durch verschiedene Defekte in den Energie (ATP) produzierenden Stoffwechselwegen der Mitochondrien verursacht sind. Will man Mitochondriopathien auf molekularer Ebene diagnostizieren, stößt man auf folgende Schwierigkeiten: (A) Ungefähr 1000 Gene sind an der Biogenese des Mitochondriums beteiligt. Die Dysfunktion jedes einzelnen dieser Gene kann potentiell zur Mitochondriopathie führen. (B) Mitochondriale Proteine werden durch zwei Genome, durch die mitochondriale und durch die nukleäre DNA kodiert. (C) Die klinischen Symptome der Patienten weisen selten auf die molekulare Diagnose, da der Phänotyp oft nur auf einem sekundären Energiemangel beruht. In der Regel besteht keine sichere Genotyp-Phänotyp-Relation. Mit den gegenwärtig zur Verfügung stehenden Methoden lassen sich bei nur 20% der Patienten Mutationen finden. Wir wollten daher eine neue Screening-Methode entwickeln, mit deren Hilfe wir hoffen, die Aufspürungsrate für mitochondriale Mutationen zu erhöhen. Die Gesamtheit der Proteine einer Organelle oder einer ganzen Zelle (ihr "Proteom") stellt das Verbindungsglied zwischen Geno- und Phänotyp dar. Aus diesem Grunde wollten wir das mitochondriale Proteom von gesunden Kontrollpersonen und von Patienten mit Mitochondriopathien untersuchen. Protein-Muster, die zwischen diesen beiden Gruppen abweichen, könnten die Aufmerksamkeit auf Gene und Proteine richten, die an der Entstehung des Krankheits-Phänotyps beteiligt sind. Um solch eine vergleichende Studie durchzuführen, muß zunächst eine Referenzkarte des normalen mitochondrialen Proteoms erstellt werden. In meinem Dissertationsprojekt habe ich diese grundlegende Arbeit durchgeführt und zahlreiche Proteine auf der Proteomkarte menschlicher Mitochondrien identifiziert, die aus Epstein-Barr-Virus-transformierten lymphoblastoiden Zellen gewonnen worden waren. Ich wählte diese Zellsorte als Untersuchungsmaterial, da sie nicht nur einfach von Patienten gewonnen werden, sondern auch potentiell permanent wachsen kann. Dies erlaubt die Züchtung einer hohen Zellzahl ohne übermäßigen Aufwand. Ich optimierte ein Protokoll zur Zentrifugation in einem hybriden Gradienten, mit dem genug gereinigte Mitochondrien aus 108 Zellen gewonnen werden konnten. Für die Referenzkarte benutzte ich die lymphoblastoide Zellline einer gesunden Kontrollperson. Die Methode der Wahl zur Proteinidentifikation in Proteom-Projekten ist die zweidimensionale Proteinelektrophorese gekoppelt mit der MALDI-TOF-Massenspektrometrie. Ich entdeckte mehr als 400 Punkte in meinem silbergefärbten zweidimensionalen Gel und analysierte die 141 stärksten Punkte nach in-gel Trypsin-Verdau und anschließender MALDI-TOF-Massenspektrometrie in einem Verfahren, das als "Peptide Mass Fingerprinting" (Peptidmassen-Fingerabdruck) bezeichnet wird. Mit Hilfe entsprechender Datenbanken konnte ich schließlich 115 verschiedene Proteinpunkte (entsprechen 95 verschiedenen Proteinen) identifizieren. 90 dieser Punkte (entsprechend 74 verschiedenen Proteinen) waren sicher mitochondrialer Herkunft und sind Komponenten aller wesentlichen im Mitochondrium lokalisierten Stoffwechselwege. 16 der 74 identifizierten mitochondrialen Proteine gehören zur Atmungskette. Obwohl 18 mitochondriale Proteine in der Datenbank SWISS-PROT als "Membran-assoziiert" annotiert sind, identifizierte ich nur vier Proteine mit sicheren Transmembrandomänen. Ich entdeckte keine der 13 durch die mitochondriale DNA kodierten Proteine, die alle stark hydrophobe Membranproteine sind. Andere Forscher sind bei dem Versuch diese Proteine zu identifizieren, auf die gleichen Schwierigkeiten gestoßen. Mit meiner Dissertationsarbeit habe ich unsere eigene Datenbank und Referenzkarte des mitochondrialen Proteoms lyphoblastoider Zellen erstellt. Diese Daten ermöglichen nun die Analyse des mitochondrialen Proteoms von Patienten. Meine weiteren Untersuchungen auf diesem Gebiet werden sich nun auf die genetische Variabilität des Proteoms gesunder Kontrollpersonen und auf das Proteom der Patienten mit Mitochondriopathien beziehen. / Mitochondrial disorders are multisystem diseases that can be caused by any defect in the energy (ATP) generating pathways in the mitochondria. The difficulty in diagnosing mitochondrial diseases on the molecular level arises from several obstacles: (A) About 1000 genes are involved in the biogenesis of mitochondria. The dysfunction of each of them may potentially cause mitochondriopathy. (B) The mitochondrial proteins are encoded by two genomes: the mitochondrial DNA and the nuclear DNA. (C) The clinical symptoms of the patients rarely suggest a molecular diagnosis since in most cases, the phenotype is a secondary phenomenon to energy depletion. Generally there is no genotype-phenotype relation. Based on current diagnostic methods in only 20% of the patients a mutation can be found. We therefore wanted to develop a new screening method by which we hope to increase the identification rate. Since the numerous proteins of an organelle or of a whole cell (its "proteome") connect the genotype with the phenotype, we set out to study the proteome of the mitochondrion in healthy individuals and in patients with mitochondrial diseases. Deviating protein patterns between the two individuals could direct the attention to disease-specific proteins and genes, which might be involved in the expression of a disease-phenotype. In order to perform such a comparison I first had to establish a normal reference map. In my dissertation project I performed this basic task and identified numerous mitochondrial proteins on the proteome-map of human mitochondria, which had been extracted from lymphoblastoid cells. I selected Epstein-Barr-Virus-transformed lymphoblastoid cells as samples not only because they are easily obtained from patients, but also due to their potential permanent growth. This approach allows the cultivation of high cell numbers without excessive expenditure of work and cost. I optimized a protocol for hybrid gradient centrifugation, by which enough mitochondria can be purified from 108 cells. I used a cultured lymphoblastoid cell line from a normal control patient and isolated mitochondria from it by using hybrid gradient centrifugation. In proteomics the combination of the high-resolution two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time-of-flight-mass spectrometry (MALDI-TOF-MS) is currently the method of choice for protein identification. I detected more than 400 spots in a silver-stained two-dimensional gel. I analyzed the 141 strongest spots of it by trypsin in gel digestion and subsequent MALDI-TOF mass spectrometry in a process termed "peptide mass fingerprinting". After database search, I finally identified 115 protein spots (corresponding to 95 different proteins), 90 of which (corresponding to 74 different proteins) are of confirmed mitochondrial origin. These identified proteins are components of the main biological pathways located in the mitochondrion. 16 of the 74 identified mitochondrial proteins belong to the respiratory chain. Despite the fact that 18 mitochondrial proteins are annotated in the SWISS-PROT-database as "membrane associated proteins", only four of them have clear transmembrane domains. None of the proteins encoded by the mitochondrial DNA could be detected. All of them are hydrophobic membrane proteins. A similar difficulty in resolving these proteins was encountered by other research groups. With my dissertation I established our own database and reference map of the mitochondrial proteome of lymphoblastoid cells. These data will facilitate the analysis of the mitochondrial proteome in patients. My future research based on this dissertation will mainly focus on the genetic variation of the proteome of healthy individuals and on patients with mitochondrial diseases.
|
163 |
Applications de la spectrométrie de masse type MALDI-TOF à la bactériologie et à la distinction de variants génétiques / Applications of MALDI-TOF mass spectrometry to the bacteriology and to the distinction between genetics variantsMoussaoui, Louardi 05 September 2012 (has links)
L’objectif de mon travail fut de valider et d’optimiser la spectrométrie de masse de type MALDI-TOF pour l’identification et la classification d'un ensemble de bactéries pathogènes ou opportunistes chez l’homme, en enrichissant une base de données et en testant la robustesse de la méthode, afin d’obtenir une méthode rapide fixe et fiable d'acquisition de résultats. Les différents résultats obtenus ont permis la validation de la technique comme outil d’identification bactérienne fiable en routine. Elle permet désormais de caractériser les mélanges de deux bactéries voir même la différentiation d’espèces très proches comme les Shigella spp et E. coli. Nous avons montré que la technique sera encore améliorée par un outil supplémentaire de comparaison des souches pour une veille épidémiologique "en temps réel", sans investissement supplémentaire, en permettant plusieurs types d'économie. Elle apporte un gain réel dans la prise en charge du patient et le choix éclairé des antibiotiques testés pour l'antibiogramme. La technique peut aussi constituer un outil alternatif de sérotypage. / The aim of this work was to validate and optimize MALDI-TOF mass spectrometry for the identification and classification of a set of pathogens or opportunistic bacteria, by enriching a database and testing the robustness of the method, in order to obtain a quick and reliable fixed acquisition results. The different results obtained allowed the validation of the technique as a reliable tool for bacterial identification in hospital routine. In addition, we have shown that it can characterize mixtures of two bacteria and differentiate closely related species such as Shigella spp and E. coli. We demonstrate that MALDI-TOF/MS will be further enhanced by an additional tool for comparison of strains for epidemiological monitoring in "real time". The technique can also be an alternative tool for serotyping. MALDI-TOF/MS identification provides a real benefit in terms of patient care and the choice of antibiotics tested for sensitivity, without additional investment, which allows different types of economy.
|
164 |
Charakterisierung klinisch-relevanter Bakterien mittels Proteotypisierung / Characterization of clinically relevant bacteria by proteotypingEmele, Matthias Frederik 30 April 2019 (has links)
No description available.
|
165 |
Étude de la flore bactérienne et de sa résistance aux antibiotiques des produits de la pêche et de l'aquaculture / Antibiotic resistance study of bacterial flora isolated from seafood productsBriet, Arnaud 11 December 2018 (has links)
La résistance aux antibiotiques est un enjeu de santé publique mondiale. L'alimentation est une des voies de contamination des bactéries résistantes aux antibiotiques entre l'environnement et l'Homme. Toutefois, les données concernant les bactéries résistantes aux antibiotiques dans les produits aquatiques sont rares. L'objectif de ces travaux a été d'étudier la flore bactérienne et sa résistance aux antibiotiques dans les produits de la pêche et de l'aquaculture. Dans un premier temps, la flore bactérienne mésophile cultivable a été isolée de 9 matrices différentes puis identifiée par la technique MALDI-TOF et/ou du séquençage de différents gènes de ménage. Au final, 1882 isolats bactériens ont été obtenus, et 150 espèces et 57 genres bactériens ont été identifiés. Dans un deuxième temps, nous avons étudié la résistance aux antibiotiques des genres bactériens les plus fréquemment isolés de ces produits. La résistance aux antibiotiques des genres Enterococcus, Staphylococcus, Exiguobacterium, Pseudomonas, Vibrio et Proteus a donc été étudiée. Au total, 46% des isolats étaient résistants aux antibiotiques et 3% étaient multi-résistants. Les crevettes étaient le produit dans lequel le plus de souches résistantes aux antibiotiques ont été identifiée. Et dans un troisième temps, la résistance aux antibiotiques d'une collection de souche de Vibrio parahaemolyticus, espèce bactérienne pathogène alimentaire pour l'homme, a été étudiée. Concernant V. parahaemolyticus, 15% des souches étaient résistantes et 3% des souches étaient multi-résistantes. Une souche, 16-B3PA-006, isolées de crevettes importées d'Asie du Sud-Est produisait une carbapénèmase NDM-1 et était résistante à 5 classes d'antibiotiques. / Antimicrobial resistance is a threat to global public health. Human can be contaminated by antibiotic resistant bacteria through food. However, data on antimicrobial resistant bacteria in seafood are scarce. The aim of this thesis was to study seafood bacterial flora and its antimicrobial resistance. First, mesophilic flora was obtained from 9 matrixes and MALDI-TOF and housekeeping genes sequencing technics were used to identify isolates. Antimicrobial resistance of most frequently bacteria were tested. In total, 1882 isolates were obtained and 150 bacterial species and 57 genera were identified. Enterococcus, Staphylococcus, Exiguobacterium, Pseudomonas, Vibrio and Proteus were most frequently isolated and their antimicrobial resistance was studied. Antibiotic resistant bacteria accounted for 46% of isolates and multidrug resistant bacteria accounted for 3% of isolates. Antimicrobial resistant bacteria were mostly isolated from shrimps. On a side study, antimicrobial resistance of a V.parahaemolyticus strain collection isolated from seafood was characterized. Antimicrobial resistant strains accounted for 15% and multi-drug resistant bacteria accounted for 3%. A NDM-1-producing multidrug resistant strain, 16-B3PA-006 was identified from shrimps imported from South-East Asia.
|
166 |
Charakterisierung von Viridans-Streptokokken in kariösem Dentin durch biochemische Identifizierung, MALDI-TOF-MS-Analyse und speziesspezifische PCRsThiel, Juliane 28 November 2012 (has links) (PDF)
Im Rahmen der Untersuchung wurde bei 27 Patienten, die klinische Zeichen der Karies, aber keine pulpitischen Symptome zeigten, kariöses Dentin mit Hilfe eines sterilen Exkavators entnommen. Das durchschnittliche Alter der Patienten beträgt 41 Jahre und der Durchschnittswert des DMF-T-Index 12,5. Die Untersuchungsgruppe bestand zu 55,5 % aus männlichen Probanden sowie zu 44 % aus Rauchern. Nach Isolierung von 107 Reinkulturen aus den Patientenproben erfolgte die Identifizierung der oralen Streptokokken mittels eines mikrobiologischen Standardtests (RapidID-32Strep der Firma BioMérieux) und MALDI-TOF-MS-Analyse. Parallel wurden speziesspezifische PCRs der Dentinproben für S. sanguinis, S. constellatus, S. intermedius, S. anginosus, S. mutans, S. salivarius, S. oralis, S. mitis, S. gordonii und S. parasanguinis durchgeführt. Mittels MALDI-TOF-MS-Analyse konnten insgesamt sechs verschiedene Spezies oraler Streptokokken in den Dentinproben nachgewiesen werden. Am häufigsten kamen Vertreter der Mitis-Gruppe vor (in 89 % der Dentinproben), gefolgt von S. gordonii und S. sanguinis (zu 52 % und 26 % vertreten). Die MALDI-TOF-MS-Methode erwies sich als geeignetere der mit Kultivierung verbundenen Nachweismethoden. Ihre Ergebnisse wurden durch selektive PCRs einzelner Subkulturen und DNA-Sequenzierung bestätigt. Mittels der speziesspezifischen PCRs der Dentinspäne wurden zehn verschiedene Spezies oraler Streptokokken identifiziert. Vertreter der Mutans-Gruppe wurden so zu durchschnittlich 44 %, S. salivarius zu 37 % nachgewiesen. Es zeigte sich ein signifikantes Vorkommen von S. anginosus in Proben, die ebenfalls S. mutans enthielten (p= 0,00213). Alle drei Verfahren sind zur Untersuchung klinischer Proben geeignet, wobei die MALDI-TOF-MS-Analyse die genaueste Differenzierung auf Speziesebene ermöglicht. Die Non-Mutans-Streptokokken S. oralis, S. gordonii und S. anginosus scheinen die Mikroflora von kariösem Dentin zu dominieren. Sie übertrafen in der vorliegenden Arbeit in ihrem Vorkommen S. mutans in mehr als der Hälfte der untersuchten Proben. Diese Beobachtung stützt die erweiterte ökologische Plaquehypothese.
|
167 |
Carcinoma epidermóide invasivo de pênis: subexpressão dos fragmentos C3 e C4A/B do sistema complemento detectado no plasma pela plataforma proteômica ClinProt/MALDI/TOF / Invasive squamous cell carcinoma of the penis: subexpression of the fragments C3 and C4A/B of the complement system detected in plasma by proteomic platform ClinProt / MALDI / TOFPaulo Ornellas de Souza 28 August 2013 (has links)
O carcinoma epidermóide de pênis (CEP) representa 95% das neoplasias penianas e afeta quase sempre pacientes não circuncidados estando muitas vezes associado à falta de higiene local adequada e à fimose. No Brasil a sua incidência é de 2,7 % porém em algumas áreas do país pode chegar a 17% dos casos diagnosticados por ano. O tumor pode ocorrer em qualquer parte do órgão sexual masculino e o tipo de estadiamento empregado é controverso. A classificação de Broders é a mais utilizada. Estudos sugerem a relação entre o desenvolvimento do carcinoma de pênis com a infecção por HPV (Papiloma Vírus Humano). O método de avaliação dos linfonodos inguinais permanece controverso sendo difícil a diferenciação entre linfadenomegalia inflamatória reacional e metastática. O exame físico não é um preditor confiável do comprometimento linfonodal pois pacientes com linfonodos palpáveis podem não apresentar metástases. Há poucas publicações sobre os mecanismos moleculares envolvidos na gênese e progressão do CEP. Apesar de vários marcadores terem sido avaliados, atualmente a aplicação clínica destes é limitada. A maior parte dos marcadores estudados requer procedimentos invasivos para obtenção do tecido tumoral. Existe a necessidade de encontrar através de uma técnica pouco invasiva marcadores tumorais circulantes capazes de diferenciar portadores de CEP com e sem envolvimento metastático. Neste tipo de neoplasia, a descoberta de biomarcadores que avaliem o prognóstico é relevante, pois o exame físico não é um indicador confiável do comprometimento linfonodal e da sobrevida.Os objetivos foram 1) revisar e discutir a epidemiologia, a etiologia, os diversos tipos de abordagem cirúrgica e as controvérsias no tratamento cirúrgico do câncer de pênis 2) investigar através da plataforma ClinProt/ MALDI / TOF a presença de marcadores plasmáticos capazes de discriminar indivíduos saudáveis de pacientes afetados por carcinoma epidermóide de pênis (CEP) 3) avaliar a importância destes marcadores na evolução da doença. Foram coletados e analisados pela plataforma ClinProt / MALDI / TOF o plasma de 36 indivíduos saudáveis e 25 pacientes com CEP invasivo, submetidos a tratamento cirúrgico entre junho de 2010 e junho de 2011, nos serviços de urologia do Instituto Nacional de Câncer e do Hospital Mário Kröeff (Rio de Janeiro). Nossos resultados apontaram para um conjunto de dois peptídeos (A = m / z 1897,22 + -9 Da e B = m / z 2021,99 + -9 Da) que foram capazes de diferenciar pacientes com CEP de indivíduos controles. Esses peptídeos foram posteriormente identificados como fragmentos C3 e C4 A/B do sistema complemento. A validação cruzada, utilizando toda casuística apresentou 62,5% e 86,76% de sensibilidade e de especificidade, respectivamente, com uma alta sensibilidade (100%) e especificidade (97%) nos pacientes que morreram pela doença. Além disso, os pacientes com envolvimento ganglionar obtiveram uma sensibilidade e uma especificidade de 80 % e 97%, respectivamente. Ficou demonstrado que à medida que a doença progride mais subexpressos está o conjunto de peptídeos quando comparados com indivíduos saudáveis. Estes resultados podem ser úteis como ferramentas para a avaliação do prognóstico destes pacientes. / Squamous cell carcinoma of the penis (SSCP) represents 95% of penile cancers. It affects mostly uncircumcised patients and is often associated with lack of adequate local hygiene and phimosis. In Brazil, the incidence is 2.7% but in some areas of the country can reach 17% of diagnosed cases of cancer per year. The tumor can occur in any part of the sexual organ and the type of staging to be used is controversial. The Broders classification is more often used to classify tumors. Studies suggest the relationship between the development of penile carcinoma and HPV infection (Human Papilloma Virus). The evaluation method of inguinal lymph nodes remains controversial and it is difficult to differentiate inflammatory reaction from metastatic lymphadenopathy. Physical examination is not a reliable predictor of lymph node involvement since patients with palpable lymph nodes can not present metastases. There are few publications about the molecular mechanisms involved in the genesis and progression of the SSCP. Although several markers have been evaluated, currently the clinical application of these is limited. Most of the markers studied require invasive procedures for obtaining tumor tissue. There is a need to find through a minimally invasive technique circulating tumor markers able to differentiate SSCP patients with and without metastatic involvement. In this type ofmalignancythediscovery of biomarkers that assessthe prognosisis relevant since physical examination is not a reliable predictor oflymph node involvementand survival. The objectives of this study were: 1) to review and discuss the epidemiology, etiology, different types of surgical approach and controversies in the surgical treatment of penile cancer 2)to investigate via the platform ClinProt / MALDI / TOF presence of plasma markers able to discriminate healthy subjects from patients affected by squamous cell carcinoma of the penis (SCCP) 3) to evaluate the importance of these markers in disease progression. Between June 2010 and June 2011, plasma samples from 36 healthy subjects and 25 patients with penile carcinoma who underwent surgical treatment in the UrologyServicesofNational Cancer InstituteandMarioKröeffHospital were collected and analyzed by the ClinProt/MALDI/TOF platform. Our results found a cluster of 2 peptides (A=m/z 1897.22 +-9 Da and B=m/z 2021.99 +-9 Da that was able to discriminate patients from controls subjects. These peptides were further identified as C3 and C4 A/B fragments from complement system. Cross validation analysis using the whole casuistic showed 62.5% and 86.76% of sensitivity and specificity, respectively with a very high sensitivity (100%) and specificity (97%) for SCCP patients that have died by disease. Moreover, patients with lymph node involvement present a sensitivity and specificity of 80% and 97%, respectively. The results showed that as the disease progresses more under express are the cluster comparing with healthy subjects. These results may be useful as prognostic toll.
|
168 |
Carcinoma epidermóide invasivo de pênis: subexpressão dos fragmentos C3 e C4A/B do sistema complemento detectado no plasma pela plataforma proteômica ClinProt/MALDI/TOF / Invasive squamous cell carcinoma of the penis: subexpression of the fragments C3 and C4A/B of the complement system detected in plasma by proteomic platform ClinProt / MALDI / TOFPaulo Ornellas de Souza 28 August 2013 (has links)
O carcinoma epidermóide de pênis (CEP) representa 95% das neoplasias penianas e afeta quase sempre pacientes não circuncidados estando muitas vezes associado à falta de higiene local adequada e à fimose. No Brasil a sua incidência é de 2,7 % porém em algumas áreas do país pode chegar a 17% dos casos diagnosticados por ano. O tumor pode ocorrer em qualquer parte do órgão sexual masculino e o tipo de estadiamento empregado é controverso. A classificação de Broders é a mais utilizada. Estudos sugerem a relação entre o desenvolvimento do carcinoma de pênis com a infecção por HPV (Papiloma Vírus Humano). O método de avaliação dos linfonodos inguinais permanece controverso sendo difícil a diferenciação entre linfadenomegalia inflamatória reacional e metastática. O exame físico não é um preditor confiável do comprometimento linfonodal pois pacientes com linfonodos palpáveis podem não apresentar metástases. Há poucas publicações sobre os mecanismos moleculares envolvidos na gênese e progressão do CEP. Apesar de vários marcadores terem sido avaliados, atualmente a aplicação clínica destes é limitada. A maior parte dos marcadores estudados requer procedimentos invasivos para obtenção do tecido tumoral. Existe a necessidade de encontrar através de uma técnica pouco invasiva marcadores tumorais circulantes capazes de diferenciar portadores de CEP com e sem envolvimento metastático. Neste tipo de neoplasia, a descoberta de biomarcadores que avaliem o prognóstico é relevante, pois o exame físico não é um indicador confiável do comprometimento linfonodal e da sobrevida.Os objetivos foram 1) revisar e discutir a epidemiologia, a etiologia, os diversos tipos de abordagem cirúrgica e as controvérsias no tratamento cirúrgico do câncer de pênis 2) investigar através da plataforma ClinProt/ MALDI / TOF a presença de marcadores plasmáticos capazes de discriminar indivíduos saudáveis de pacientes afetados por carcinoma epidermóide de pênis (CEP) 3) avaliar a importância destes marcadores na evolução da doença. Foram coletados e analisados pela plataforma ClinProt / MALDI / TOF o plasma de 36 indivíduos saudáveis e 25 pacientes com CEP invasivo, submetidos a tratamento cirúrgico entre junho de 2010 e junho de 2011, nos serviços de urologia do Instituto Nacional de Câncer e do Hospital Mário Kröeff (Rio de Janeiro). Nossos resultados apontaram para um conjunto de dois peptídeos (A = m / z 1897,22 + -9 Da e B = m / z 2021,99 + -9 Da) que foram capazes de diferenciar pacientes com CEP de indivíduos controles. Esses peptídeos foram posteriormente identificados como fragmentos C3 e C4 A/B do sistema complemento. A validação cruzada, utilizando toda casuística apresentou 62,5% e 86,76% de sensibilidade e de especificidade, respectivamente, com uma alta sensibilidade (100%) e especificidade (97%) nos pacientes que morreram pela doença. Além disso, os pacientes com envolvimento ganglionar obtiveram uma sensibilidade e uma especificidade de 80 % e 97%, respectivamente. Ficou demonstrado que à medida que a doença progride mais subexpressos está o conjunto de peptídeos quando comparados com indivíduos saudáveis. Estes resultados podem ser úteis como ferramentas para a avaliação do prognóstico destes pacientes. / Squamous cell carcinoma of the penis (SSCP) represents 95% of penile cancers. It affects mostly uncircumcised patients and is often associated with lack of adequate local hygiene and phimosis. In Brazil, the incidence is 2.7% but in some areas of the country can reach 17% of diagnosed cases of cancer per year. The tumor can occur in any part of the sexual organ and the type of staging to be used is controversial. The Broders classification is more often used to classify tumors. Studies suggest the relationship between the development of penile carcinoma and HPV infection (Human Papilloma Virus). The evaluation method of inguinal lymph nodes remains controversial and it is difficult to differentiate inflammatory reaction from metastatic lymphadenopathy. Physical examination is not a reliable predictor of lymph node involvement since patients with palpable lymph nodes can not present metastases. There are few publications about the molecular mechanisms involved in the genesis and progression of the SSCP. Although several markers have been evaluated, currently the clinical application of these is limited. Most of the markers studied require invasive procedures for obtaining tumor tissue. There is a need to find through a minimally invasive technique circulating tumor markers able to differentiate SSCP patients with and without metastatic involvement. In this type ofmalignancythediscovery of biomarkers that assessthe prognosisis relevant since physical examination is not a reliable predictor oflymph node involvementand survival. The objectives of this study were: 1) to review and discuss the epidemiology, etiology, different types of surgical approach and controversies in the surgical treatment of penile cancer 2)to investigate via the platform ClinProt / MALDI / TOF presence of plasma markers able to discriminate healthy subjects from patients affected by squamous cell carcinoma of the penis (SCCP) 3) to evaluate the importance of these markers in disease progression. Between June 2010 and June 2011, plasma samples from 36 healthy subjects and 25 patients with penile carcinoma who underwent surgical treatment in the UrologyServicesofNational Cancer InstituteandMarioKröeffHospital were collected and analyzed by the ClinProt/MALDI/TOF platform. Our results found a cluster of 2 peptides (A=m/z 1897.22 +-9 Da and B=m/z 2021.99 +-9 Da that was able to discriminate patients from controls subjects. These peptides were further identified as C3 and C4 A/B fragments from complement system. Cross validation analysis using the whole casuistic showed 62.5% and 86.76% of sensitivity and specificity, respectively with a very high sensitivity (100%) and specificity (97%) for SCCP patients that have died by disease. Moreover, patients with lymph node involvement present a sensitivity and specificity of 80% and 97%, respectively. The results showed that as the disease progresses more under express are the cluster comparing with healthy subjects. These results may be useful as prognostic toll.
|
169 |
Assessing the diversity of agrobacterial populations / Évaluation de la diversité des populations d'AgrobacteriumShams, Malek 19 December 2012 (has links)
Les bactéries du genre Agrobacterium forment un ensemble taxonomiquement diversifié composé de nombreuses espèces, présent dans la plupart des sols et des rhizosphère. Les agrobactéries sont le plus souvent anodines voire stimulatrices de la croissance des plantes. Par contre, celles qui hébergent un plasmide Ti induisent la maladie de la galle du collet à de nombreuses plantes d'intérêt agronomique. Dans ce contexte, nous avons d'une part donné l'état actuel des connaissances sur la taxonomie du genre Agrobacterium, et nous avons fait une revue des méthodes d'isolement et de typage de ces bactéries. D'autre part, nous avons cherché à mettre au point des méthodes d'identification rapides et fiables des différentes espèces d'agrobactérie. La méthode de MALDI-TOF MS a permis d'identifier les espèces mais elle n'était pas assez résolutive pour typer des souches et encore moins la présence de plasmides Ti dans les isolats. Nous avons alors développé des amorces de PCR spécifiques de 17 espèces, du genre Agrobacterium et de la famille Rhizobiaceae. Ces amorces se sont révélées efficaces pour identifier les bactéries cultivées et aussi pour détecter leur présence dans des communautés microbiennes. Nous avons utilisé ces outils pour étudier la répartition des agrobactéries à l'échelle d'un pays, d'une station et entre sols nus et sols rhizosphériques en utilisant soit des isolats soit des ADN extraits des différents environnements. Enfin, nous avons montré que le clonage-séquençage ou le séquençage à haut débit d'amplicons obtenus à partir d’ADN de communautés microbiennes nous permettaient de connaître la diversité des populations d'agrobactéries / Agrobacterium are Alphaproteobacteria common in most soils that closely interact with plants in two respects. Firstly, they are rhizospheric bacteria saprophytically living in the rhizosphere of numerous plants and they are likely beneficial to plants. Secondly, when they harbor a dispensable Ti plasmid (i.e. tumor inducing plasmid), agrobacteria are plant pathogens able to cause the crown gall disease to most dicots and gymnosperms and some monocots. An epidemiological survey of crown gall thus also requires expert determination of the Agrobacterium taxonomy. In this thesis we evaluated the usefulness of MALDI-TOF MS technique as a high throughput tool to determine and classify agrobacteria. Then we set up a recA-based PCR method to accurately and exhaustively assess agrobacterial diversity either of isolated agrobacteria or directly in various biotopes. We applied standard biochemical, recA-based and Ti plasmid-based identification methods to study the prevalence of pathogenic and non-pathogenic agrobacteria at the country and local scales. Finally, we tested whether analyzing the internal composition of recA amplicons could be a way to directly assess the micro-diversity of agrobacterial populations using cloning sequencing or pyrosequencing approaches. The later methodology was applied to establish the actual field diversity of Agrobacterium and to evaluate whether plant genotypes differentially select agrobacteria in their root systems, providing first data upon biotic factors shaping the population structure of agrobacteria
|
170 |
Identification de marqueurs épidémiologiques par spectrométrie de masse de type MALDI-TOF : application aux principales espèces bactériennes responsables d'infections nosocomiales / Identification of epidemiological markers by MALDI-TOF mass spectrometry : application to the main species responsible for nosocomial infectionsSauget, Marlène 18 November 2016 (has links)
Le typage bactérien est une mesure de contrôle essentielle pour lutter contre la diffusion des bactéries multirésistantes, mais les techniques actuelles sont longues et coûteuses. L'objectif de cette thèse était d'évaluer la capacité de la technique MALDI-TOF MS à typer les 3 principales espèces bactériennes responsables d'infections nosocomiales - Escherichia coli, Staphylococcus aureus et Pseudomonas aeruginosa. L'analyse par MALDI-TOF MS permet d'identifier les souches de E. coli appartenant au phylogroupe B2, souches les plus virulentes parmi les souches extra-intestinales, et au STI 31, clone très impliqué dans la dissémination des P-lactamases à spectre étendu. Chez S. aureus, cette technique reconnait les souches appartenant au CC398, impliquées dans une proportion importante d'infections graves chez des personnes fragiles. La technique MALDI-TOF MS identifie également cinq clones de P. aeruginosa à haut risque épidémique - STI 11, STI 75, ST235, ST253, ST395. Si nous avons confirmé des pics caractéristiques du phylogroupe B2 décrit également par d'autres auteurs, les pics biomarqueurs identifiant E. coli ST131 ou des clones épidémiques de S. aureus varient suivant les études. Différents paramètres peuvent influencer les résultats de typage par MALDI-TOF MS et doivent donc être standardisés. La technique MALDI-TOF MS permet d'identifier certains clones épidémiques. En gardant à l'esprit que le choix d'une méthode de typage doit être fait en fonction des objectifs mais aussi des performances des différents systèmes disponibles, la technique MALDI-TOF MS pourrait se positionner comme un outil de typage de première ligne. / Bacterial typing is crucial to tackle the spread of bacterial pathogens but current methods are time-consuming and costly. The objective of this study was to evaluate the ability of MALDI-TOF MS to type the 3 main bacterial species re.sponsible for nosocomial infections - Escherichia coti, Staphylococcus aureus and Pseudomonas aeruginosa. Analysis of MALDI-TOF mass spectra allow the identification (i) of E. coti isolates belonging to phylogroup B2, that fosters the most virulent extra-intestinal strains, and (ii) of E. coli STl 31, a clone involved in the dissemination of extended-spectrum β-lactamases. MALDI-TOF MS also recognizes S. aureus isolates belonging to CC398, a pathogen responsible for invasive infections in fragile patients and associated with a higher 30-day mortality. Furthermore the MALDI-TOF MS based typing method identifies the major high risk epidemic clones of P. aeruginosa STl 11, STl 75, ST235, ST253, and ST395. We confirmed phylogroup B2 specific peaks also described by other authors. However the identification of E. coli STl 31 or epidemic clones of S. aureus is based on biomarkers that differs between studies. Different parameters can influence the MALDI-TOF MS typing results and must therefore be standardized. MALDI-TOF-based typing methods allow the detection of epidemic pathogens. Keeping in mind that the choice of a method for routine bacterial typing should be made according to the objectives but also the performance of the different systems available, the MALDI-TOF MS technique could become a first-line typing method.
|
Page generated in 0.2698 seconds